MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ocata Therapeutics Company Profile (NASDAQ:OCAT)

Consensus Ratings for Ocata Therapeutics (NASDAQ:OCAT) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $8.25 (2.60% downside)

Analysts' Ratings History for Ocata Therapeutics (NASDAQ:OCAT)
Show:
DateFirmActionRatingPrice TargetActions
2/23/2016Cantor FitzgeraldReiterated RatingHold$8.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Maxim GroupReiterated RatingBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha